Immune-Based Combination Therapies for Advanced Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Immune-Based Combination Therapies for Advanced Hepatocellular Carcinoma

Published:2023-09 Issue: Volume:Volume 10 Page:1445-1463
ISSN:2253-5969
Container-title:Journal of Hepatocellular Carcinoma
language:en
Short-container-title:JHC

Author:

Carloni Riccardo,Sabbioni Simone^ORCID,Rizzo Alessandro,Ricci Angela Dalia,Palloni Andrea,Petrarota Cataldo,Cusmai Antonio,Tavolari Simona,Gadaleta-Caldarola Gennaro,Brandi Giovanni

Publisher

Informa UK Limited

Subject

General Medicine

Reference119 articles.

1. World Health Organization. Cancer today; 2022. Available from: http://gco.iarc.fr/today/home. Accessed August 29, 2023.

2. Epidemiology of Hepatocellular Carcinoma

3. Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates

4. Strategies to increase the resectability of hepatocellular carcinoma

5. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Promising first‐line immuno‐combination therapies for unresectable hepatocellular carcinoma: A cost‐effectiveness analysis;Cancer Medicine;2024-08

2. Exploring the Role of GITR/GITRL Signaling: From Liver Disease to Hepatocellular Carcinoma;Cancers;2024-07-22

3. Clinical efficacy of lenvatinib, trans-arterial chemoembolization, and PD-1/L1 inhibitors in advanced hepatocellular carcinoma: a systematic review and network meta-analysis;Clinical and Translational Oncology;2024-04-26

4. Immune Cytolytic Activity and Strategies for Therapeutic Treatment;International Journal of Molecular Sciences;2024-03-23